• Overview
  • Eligibility
  • More info
  • Locations

Evaluation of an Outpatient Pharmacy Clinical Services Program on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases (NCT03024307)

This is a randomised trial on the efficacy of an Outpatient Pharmacy Clinical Services Program (OPCSP) on adherence and clinical outcomes among patients with rheumatic diseases.The purpose of this study is to evaluate: 1. rates of medication adherence in the OPCSP program compared with usual care in an integrated health care system. 2. total direct costs and clinical outcomes in the OPCSP program compared with usual care in an integrated health care system.
  • Other: pharmacists involved OPCSP
    This was an open labelled randomised study. Rheumatic diseases patients were recruited and arbitrarily divided into the intervention group (usual care plus OPCSP) and the non-intervention group (usual care only). Those enrolled in the research were scheduled for follow-up for eight consecutive visits. Improvements in lab results and direct costs were compared longitudinally (pre and post analysis) between the groups.
    Ages eligible for Study
    18 Years to 70 Years
    Genders eligible for Study
    All
    Accepts Healthy Volunteers
    No
    Inclusion Criteria:
    • Willingness of the subject to participate in the study, proven by signing the informed consent;
    • Systemic lupus erythematosus (SLE), as defined by meeting at least 4 of 11 classification criteria of American College of Rheumatology for the classification of systemic lupus erythematosus, either sequentially or coincidentally. The 4 criteria doesn't need to be present at the time of study enrollment;
    • Patients fulfilled the American College of Rheumatology criteria for RA and AS;
    Exclusion Criteria:
    • Patients who are unwilling to sign the inform consent;
    • Pregnancy or lactation
    This is a randomised trial on the efficacy of an Outpatient Pharmacy Clinical Services Program (OPCSP) on adherence and clinical outcomes among patients with rheumatic diseases.Three types of rheumatic diseases were included in the study, Systemic lupus erythematosus (SLE), Ankylosing spondylitis (AS), and Rheumatoid Arthritis(RA). The purpose of this study is to evaluate:

    1. rates of medication adherence in the OPCSP program compared with usual care in an integrated health care system.

    2. total direct costs and clinical outcomes in the OPCSP program compared with usual care in an integrated health care system.

    1 locations

    China (1)
    • South Campus, Ren Ji Hospital
      recruiting
      Shanghai, China, 201112
    Status:
    recruiting
    Type:
    Interventional
    Phase:
    -
    Start:
    17 January, 2017
    Updated:
    21 January, 2017
    Participants:
    600
    Apply
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!